US Tariffs Threaten Swiss Pharmaceutical Industry

The US has imposed 100 percent tariffs on Swiss pharmaceutical products, sparking concern in Switzerland. Basel, a major pharma hub, is lobbying for its industry as the Swiss government seeks a nation

By Liam Carter